聚合酶链反应产物特异性的阳性证实

以聚合酶链反应(PCR)法在mRNA水平检测T淋巴细胞受体α链可变区基因表达为例,介绍用~(32)P标记的人工合成寡核苷酸探针对PCR产物特异性作阳性证实的方法。该法以干琼脂糖凝胶作为支持物、相对较为简便和省财。用Ca探针以干凝胶作支持物的杂交结果,证实29个Vα基因的PCR扩增中物均为特异性的,放射自显影的带型与位置和溴乙锭染色所示完全吻合。     

咳嗽从肾论治

基于中医有关古代文献和个人的临床经验，作者举例说明咳嗽不仅能从肺治疗，从肾治疗也是行之有效的方法。     

MRI的选购定位

对MRI若干主要参数进行总结,结合实际应用体会,对我院MRI设备选购进行讨论,以期对MRI设备的选购定位提供参考.     

人肝癌裸鼠移植模型阿霉素诱导法建立肝癌多药耐药细胞系

目的:建立人肝癌多药耐药细胞系研究其耐药特性及机制.方法:给予移植人肝癌细胞的裸小鼠腹腔注射阿霉素(ADM)长期诱导,获得多药耐药细胞系BEL-7402/ADM.相差显微镜和HE染色观察细胞,MTT法检测耐药细胞的多药耐药性,流式细胞术检测耐药细胞表面多药耐药基因(mdr)的表达产物P糖蛋白(P-gp)、多药耐药相关蛋白(MRP)及谷胱甘肽硫转移系统(GSH/GST)的表达.结果:BEL-7402/ADM对多种抗癌药物产生耐药,对阿霉素的耐药性提高了20.33倍.BEL-7402/ADM细胞表面P-gp和MRP表达阳性,与对照细胞BEL-7402表达比较,差异十分显著(P<0.01).GSH/GST表达无明显变化.结论:BEL-7402/ADM具有明确的多药耐药性,该模型的建立对研究肝癌多药耐药的产生及逆转具有重要价值.     

Lipoprotein (a) levels in those with high molecular weight apo (a) isoforms may remain low in a significant proportion of patients with end-stage renal disease.

BACKGROUND: Studies have reported an increase in median Lipoprotein (Lp) (a) in patients with high molecular weight (HMW) apolipoprotein (apo) (a) isoforms and renal impairment. Some studies identify Lp (a) levels as a risk factor for vascular disease in renal failure whilst others have demonstrated an association with apo (a) isoform type and vascular disease. METHODS: A total of 239 patients at end-stage renal failure (ESRF) were studied prior to the initiation of dialysis. Blood was taken for Lp (a) levels and apo (a) isoforms. Clinical vascular disease (CVD) was assessed on the basis of clinical history and Rose questionnaire. The control group for Lp (a) levels consisted of 228 healthy volunteers. RESULTS: Despite a higher median Lp (a) level in those with HMW isoforms, 30% of patients had Lp (a) levels <10 mg/dl. Overall, 49% patients were identified as having CVD. Diabetes, smoking history and Lp (a) levels were significantly associated with CVD in logistic regression analysis, although when patients with low molecular weight (LMW) and HMW isoforms were analysed separately, Lp (a) levels were not significantly associated with CVD in those with LMW isoforms. The rates of CVD in those with HMW isoform and low Lp (a) levels were significantly lower than those with HMW isoforms and elevated Lp (a) levels, 34 vs 57% (P < 0.01). CONCLUSIONS: Although median Lp (a) levels in those patients at ESRF with HMW isoforms are higher than controls, in a third of such patients Lp (a) levels remain relatively low. These patients have lower rates of CVD than those with high levels of Lp (a).     

ENDOSCOPIC PANCREATIC STENTING IN CHRONIC PANCREATITIS WITH DUCTAL DILATION PROXIMAL TO A STRICTURE: A SAFE and EFFECTIVE PROTOCOL

After removal of intraductal stones, a 10‐Fr or 7‐Fr pancreatic stent was placed in 16 patients with upstream ductal dilation proximal to a stricture of the main pancreatic duct. Stents were removed after a mean duration of 52.5 days. Nine patients underwent repeated stenting. About one year after removal of the initial stent, when the remaining upstream ductal dilation was found on follow‐up pancreatograms, the next stent was replaced. Repeated stenting improved outflow of pancreatic juice more effectively than one‐time stenting. Correlation between long‐term pain relief without recurrence of intraductal stones and reduction of duct diameter was also shown. Stent occlusion was observed in 14 of 30 stents. Stent occlusion was frequently associated with recurrence of pancreatitis and intraductal stones, and was also associated with morphologic changes in the pancreatic ductal system. Although there were no significant differences between stent patency of the initial stents and that of the next stents, stent patency of 10‐Fr stents was superior to that of 7‐Fr stents. 10‐Fr stents should be removed within 8 weeks and 7‐Fr stents should be removed within 4 weeks for the prevention of stent occlusion. Repeated stenting with short‐term stenting is therefore considered a safe and effective protocol of endoscopic pancreatic stenting.     

Inhibitory Effect of Angiogenesis Inhibitor TNP—470 on Human ACHN Renal Cell Carcinoma

Angiogenesis,the formation of new bloodvessels,is necessary for the growth of tumors andtheir metastasis.TNP- 470 is a synthetic analogueof fumagillin and has stronger antiangiogenic　 ac-tivity and less side- effects than fumagillin.Thiscompound has been reported to suppress the prolif-eration and metastasis of various kinds of tu-mors[1] . Using nude mice xenografts of ACHN hu-man renal cell carcinoma ( RCC) ,the presentstudyattempted to examine the action of TNP- 470 ongrowth,metastasi…     

涎腺腺癌细胞系对葫芦素BE的敏感性研究

目的 观察其有多种生物活性的葫芦素BE对涎腺腺癌细胞的杀伤作用。方法 用四唑盐显色法(MTT法)检测人腺样食性癌(ACC-M)和粘液表皮样癌(MEC-1)细胞系对葫芦素BE的敏感性实验。结果 葫芦素BE对两种腺癌细胞系均有较高的相对抗肿瘤活性(RAA值分别为345、148)。结论 实验结果为葫芦素BE治疗涎腺腺癌的进一步研究提供了重要依据。